Navigation Links
Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
Date:1/8/2010

ss. He also was managing director of SmithKline's pharmaceutical operations in the Philippines. He also held senior marketing positions in Canada and Spain and had product planning responsibilities for SmithKline in Latin America.

Mr. Roche serves as a member of the board of directors for Intercept Pharmaceuticals.

About Cephalon, Inc.

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of many unique products in four core therapeutic areas: central nervous system, inflammatory diseases, pain and oncology. A member of the Fortune 1000 and the S&P 500 Index, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota.

Cephalon has a growing presence in Europe, the Middle East and Africa. The Cephalon European headquarters and pre-clinical development center are located in Maisons-Alfort, France, just outside of Paris. Key business units are located in England, Ireland, France, Germany, Italy, Spain, the Netherlands for the Benelux countries, and Poland for Eastern and Central European countries. Cephalon Europe markets more than 30 products in four areas: central nervous system, pain, primary care and oncology.

The company's proprietary products in the United States include: NUVIGIL® (armodafinil) Tablets [C-IV], TREANDA® (bendamustine hydrochloride) for Injection, AMRIX® (cyclobenzaprine hydrochloride extended-release capsules), FENTORA® (fentanyl buccal tablet) [C-II], TRISENOX® (arsenic trioxide) injection, GABITRIL® (tiagabine hydrochloride), PROVIGIL® (modafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citra
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Provides Update on Regulatory Review of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
2. Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
3. Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
4. Cephalon Net Sales Increase 9% and Net Cash from Operations Surpasses $200 Million in the Third Quarter 2009
5. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
6. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
7. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
8. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
9. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
10. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
11. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ST. PAUL, Minn. , July 7, 2015 /PRNewswire/ ... and manufacturer of devices that use neuroblocking technology to ... the pricing of its previously announced public offering of 32,000,000 ... stock and one Series A warrant to purchase one ... $0.50 per unit. Investors whose purchase of units in ...
(Date:7/7/2015)... -- Oasmia Pharmaceutical AB, a developer of ... oncology, has filed a registration statement on Form F-1/A ... the proposed public offering of ordinary stock and listing ... Depositary Shares, representing ordinary shares, to be offered, and ... been determined. An Investor Roadshow will be conducted in ...
(Date:7/7/2015)... July 7, 2015 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral ... a non-binding Letter of Intent (LoI) for an investment ... with Sinopharm Capital Management Co. Ltd. and Hefei Life ... (Sinopharm/ Hefei ) potentially valued at $50,000,000 ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 2Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 3Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 4Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50,000,000 Investment and Licensing Deal in China 5
... , , MADISON, N.J., ... ), the world,s leading provider of diagnostic testing, information and ... 21st Annual Piper Jaffray Healthcare Conference in New York City. ... at 9:30 a.m. Eastern Time. , During the conference, the ...
... Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today ... Healthcare Conference on Tuesday, December 1, 2009 at 9:00 a.m. ... at The New York Palace Hotel. Steve Worland, Ph.D., ... overview of Anadys and its clinical development programs, ANA598 and ...
Cached Medicine Technology:Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2
(Date:7/7/2015)... ... July 07, 2015 , ... Dermatologists ... Aspen Ideas Festival (AIF), identifying 18 possible melanomas and 46 potential non-melanoma skin ... with additional testing. , The Aspen Ideas Festival, which was held from June ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... that the two firms have merged to form Camber Collective. Camber Collective ... sectors. The merger combines SwitchPoint’s strategy consulting expertise with Hope Consulting’s deep ...
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois cannabis cultivation ... limited to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) board and ... and are committed to making sure patients have access to cannabis as a ...
(Date:7/7/2015)... ... July 07, 2015 , ... Summer is a great ... however, so Amica Insurance is sharing some safety tips. , Jean Tapley, senior wellness ... , Leisure activities/sports, , Start slowly. Going from no activity ...
(Date:7/7/2015)... Michigan (PRWEB) , ... July 07, 2015 , ... ... the heart of Downtown Detroit was the site of the National Baptist Convention ... Wellness Initiative. Focusing on encouraging and promoting the collaboration of churches and their ...
Breaking Medicine News(10 mins):Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Amica Insurance Has 7 Summer Safety Tips 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3
... In a statement issued today, the nonpartisan watchdog group ... (R-Ky.) recent statements opposing health care reform as "hazardous to ... at the expense of working families and small business owners ... Times cited Sen. McConnell,s opposition to health care ...
... , , More than 45 million Americans suffer from headaches ... up with the National Headache Foundation (NHF), EHE International is helping ... annually. In a unique approach, the NHF and EHE are ... 115 square-foot display window at 10 Rockefeller Plaza, for the month ...
... PRINCETON, N.J., June 8 Covance Inc. (NYSE: CVD ... Company,s 29th Annual Growth Stock Conference on Tuesday, June 9, 2009 ... webcast of the presentation at www.covance.com . ... on 10 minutes early. , , , Covance, with ...
... below listed groups issued the following statement regarding the ... 9-10: , , As advocates for people living ... carefully consider the importance of viable treatment options for ... Access to safe and effective treatments, including more ...
... in clinical cancer research published in high-impact journals, according ... of Michigan Comprehensive Cancer Center. Taking into account ... studies included a smaller proportion of women than should ... cancer types that were not gender specific, including colon ...
... Standard added to Continua Health Alliance Design Guidelines , ... -- The ZigBee(R) Alliance announced today that the ... Continua,s new low power local area network (LAN) standard. ... of devices on a single network. Continua recommends ZigBee ...
Cached Medicine News:Health News:Watchdog Group Blasts McConnell for Putting Insurance Donors Before Health Care Reform 2Health News:EHE International Supports the National Headache Foundation 2Health News:Joint Statement on Atypical Antipsychotic Use in Children 2Health News:Joint Statement on Atypical Antipsychotic Use in Children 3Health News:Women underrepresented in cancer research, U-M study finds 2Health News:ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 2Health News:ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: